The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Patrick M. Moriarty
Department of Internal Medicine
Division of Clinical Pharmacology
University of Kansas Medical Center
Kansas City
USA
Name/email consistency: high
- Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4. Moriarty, P.M., Luyendyk, J.P., Gibson, C.A., Backes, J.M. Am. J. Cardiol. (2010)
- Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia. Moriarty, P., Sosland, R., Gibson, C., Belmont, J. Ther. Apher. Dial (2010)
- LDL-apheresis Therapy. Moriarty, P.M. Curr. Treat. Options. Cardiovasc. Med (2006)
- Effect of low-density lipoprotein apheresis on lipoprotein-associated phospholipase A2. Moriarty, P.M., Gibson, C.A. Am. J. Cardiol. (2005)
- Association between hematological parameters and high-density lipoprotein cholesterol. Moriarty, P.M., Gibson, C.A. Curr. Opin. Cardiol. (2005)
- Effect of low-density lipoprotein cholesterol apheresis on blood viscosity. Moriarty, P.M., Gibson, C.A., Kensey, K.R., Hogenauer, W. Am. J. Cardiol. (2004)
- Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses. Moriarty, P.M., Gibson, C.A. Curr. Atheroscler. Rep (2001)
- Using both "relative risk reduction" and "number needed to treat" in evaluating primary and secondary clinical trials of lipid reduction. Moriarty, P.M. Am. J. Cardiol. (2001)
- C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis. Moriarty, P.M., Gibson, C.A., Shih, J., Matias, M.S. Atherosclerosis (2001)
